Year |
Citation |
Score |
2013 |
Kramer J, Obejero-Paz CA, Myatt G, Kuryshev YA, Bruening-Wright A, Verducci JS, Brown AM. MICE models: superior to the HERG model in predicting Torsade de Pointes. Scientific Reports. 3: 2100. PMID 23812503 DOI: 10.1038/Srep02100 |
0.368 |
|
2010 |
Kuryshev YA, Bruening-Wright A, Brown AM, Kirsch GE. Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels. Journal of Cardiovascular Pharmacology. 56: 420-30. PMID 20930594 DOI: 10.1097/FJC.0b013e3181f1d21b |
0.43 |
|
2007 |
Bruening-Wright A, Lee WS, Adelman JP, Maylie J. Evidence for a deep pore activation gate in small conductance Ca2+-activated K+ channels. The Journal of General Physiology. 130: 601-10. PMID 17998394 DOI: 10.1085/jgp.200709828 |
0.667 |
|
2007 |
Bruening-Wright A, Elinder F, Larsson HP. Kinetic relationship between the voltage sensor and the activation gate in spHCN channels. The Journal of General Physiology. 130: 71-81. PMID 17591986 DOI: 10.1085/Jgp.200709769 |
0.623 |
|
2007 |
Bruening-Wright A, Larsson HP. Slow conformational changes of the voltage sensor during the mode shift in hyperpolarization-activated cyclic-nucleotide-gated channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 270-8. PMID 17215386 DOI: 10.1523/Jneurosci.3801-06.2007 |
0.593 |
|
2003 |
Lee WS, Ngo-Anh TJ, Bruening-Wright A, Maylie J, Adelman JP. Small conductance Ca2+-activated K+ channels and calmodulin: cell surface expression and gating. The Journal of Biological Chemistry. 278: 25940-6. PMID 12734181 DOI: 10.1074/Jbc.M302091200 |
0.592 |
|
2002 |
Bruening-Wright A, Schumacher MA, Adelman JP, Maylie J. Localization of the activation gate for small conductance Ca2+-activated K+ channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6499-506. PMID 12151529 DOI: 10.1523/Jneurosci.22-15-06499.2002 |
0.677 |
|
2001 |
Shmukler BE, Bond CT, Wilhelm S, Bruening-Wright A, Maylie J, Adelman JP, Alper SL. Structure and complex transcription pattern of the mouse SK1 K(Ca) channel gene, KCNN1. Biochimica Et Biophysica Acta. 1518: 36-46. PMID 11267657 DOI: 10.1016/S0167-4781(01)00166-X |
0.587 |
|
1999 |
Khawaled R, Bruening-Wright A, Adelman JP, Maylie J. Bicuculline block of small-conductance calcium-activated potassium channels. Pflã¼Gers Archiv : European Journal of Physiology. 438: 314-21. PMID 10398861 DOI: 10.1007/S004240050915 |
0.569 |
|
Low-probability matches (unlikely to be authored by this person) |
2015 |
Obejero-Paz CA, Bruening-Wright A, Kramer J, Hawryluk P, Tatalovic M, Dittrich HC, Brown AM. Quantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac Risk. Scientific Reports. 5: 17623. PMID 26616666 DOI: 10.1038/srep17623 |
0.251 |
|
2010 |
Peng S, Lacerda AE, Kirsch GE, Brown AM, Bruening-Wright A. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. Journal of Pharmacological and Toxicological Methods. 61: 277-86. PMID 20153443 DOI: 10.1016/j.vascn.2010.01.014 |
0.238 |
|
2011 |
Peng S, Bruening-Wright A, Kirsch GE, Lacerda AE, Brown AM. Characterization of the L-type calcium current in human stem cell-derived cardiomyocytes Journal of Pharmacological and Toxicological Methods. 64: e5. DOI: 10.1016/j.vascn.2011.03.022 |
0.127 |
|
2014 |
Kirsch AG, Obejero-Paz CA, Bruening-Wright A. Functional Characterization of Human Stem Cell-Derived Cardiomyocytes. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. 2014. PMID 25152802 DOI: 10.1002/0471141755.ph1112s64 |
0.109 |
|
2019 |
Obejero-Paz CA, Wolford R, Bruening-Wright A. Metabolic regulation of the electrophysiology and contractility of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM). Journal of Pharmacological and Toxicological Methods. 99: 106595. PMID 31963066 DOI: 10.1016/j.vascn.2019.05.035 |
0.058 |
|
2019 |
Shaffer J, Ross J, Obejero-Paz CA, Waines M, Bruening-Wright A, Roche B. Can cardiovascular liabilities be detected earlier in drug development? Assessing the translation of tyrosine kinase inhibitors from cardiomyocytes and isolated hearts to whole animal. Journal of Pharmacological and Toxicological Methods. 99: 106595. PMID 31962966 DOI: 10.1016/j.vascn.2019.05.135 |
0.024 |
|
Hide low-probability matches. |